SCHEMBL4095133

SCHEMBL4095133

CC1CNCCN1CCN

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3095725 0.89 KEAP1 (0.31) DPP4
SCHEMBL29300892 0.84 TDP1 (0.31) TDP1
SCHEMBL29784806 0.84 TDP1 (0.31) TDP1
Tert-Butyl Formate SCHEMBL28776243 0.82 TDP1 (0.35) TDP1
Tert-Butyl Formate SCHEMBL28776244 0.82 TDP1 (0.35) TDP1
SCHEMBL3100349 0.82 TAAR1 (0.37) TDP1
SCHEMBL18705797 0.82 TAAR1 (0.37) TDP1
SCHEMBL13418867 0.82 TAAR1 (0.37) TDP1
SCHEMBL25225090 0.80
SCHEMBL294124 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115703731-B Imide compound, preparation method and application thereof 中国石油化工股份有限公司 2025-02-11 CN claimed
CN-118344917-A Lubricating oil composition and preparation method thereof 中国石油化工股份有限公司 2024-07-16 CN claimed
CN-116789582-A Imide compound and preparation method and application thereof 中国石油化工股份有限公司 2023-09-22 CN claimed
CN-115703731-A Imide compound and preparation method and application thereof 中国石油化工股份有限公司 2023-02-17 CN claimed
CN-115703731-B Imide compound, preparation method and application thereof 中国石油化工股份有限公司 2025-02-11 CN disclosed
CN-118344917-A Lubricating oil composition and preparation method thereof 中国石油化工股份有限公司 2024-07-16 CN disclosed
CN-117624137-A Triazine skeleton small molecule heparin reversal agent and preparation method and application thereof 中国药科大学 2024-03-01 CN disclosed
CN-116789582-A Imide compound and preparation method and application thereof 中国石油化工股份有限公司 2023-09-22 CN disclosed
CN-115703731-A Imide compound and preparation method and application thereof 中国石油化工股份有限公司 2023-02-17 CN disclosed
US-20160304445-A1 N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES BASF SE (DE) 2016-10-20 US disclosed
US-20160304445-A1 N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES BASF SE (DE) 2016-10-20 US disclosed
WO-2015086293-A1 N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES BASF SE (DE) 2015-06-18 WO disclosed
CN-101370800-A Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors AVENTIS PHARMA SA (FR) 2009-02-18 CN disclosed
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases ELI LILLY AND COMPANY 2008-12-11 US disclosed
EP-1228061-A4 DIPEPTIDYL PEPTIDASE IV INHIBITORS AND METHODS OF MAKING AND USING DIPEPTIDYL PEPTIDASE IV INHIBITORS GUILFORD PHARM INC (US) 2004-12-15 EP disclosed
EP-1228061-A1 DIPEPTIDYL PEPTIDASE IV INHIBITORS AND METHODS OF MAKING AND USING DIPEPTIDYL PEPTIDASE IV INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 2002-08-07 EP disclosed
WO-2001034594-A1 DIPEPTIDYL PEPTIDASE IV INHIBITORS AND METHODS OF MAKING AND USING DIPEPTIDYL PEPTIDASE IV INHIBITORS GUILFORD PHARMACEUTICALS, INC. (US) 2001-05-17 WO disclosed
US-4992150-A Telomer with alpha-olefin;oil and fuel additive NIPPON OIL CO, LTD. (JP) 1991-02-12 US disclosed
US-4946612-A Lubricating oil composition for sliding surface and for metallic working and method for lubrication of machine tools using said composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1990-08-07 US disclosed
EP-0190586-A1 Triazine dyes, their preparation and their use BAYER AG (DE) 1986-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases NFKBIA, IKBKB, IKBKG DPP4 2414/4885TDP1 810/4885ALOX15 1255/4885
US-20160304445-A1 N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES PARN, NIT2, NAT1 DPP4 4594/4885TDP1 979/4885ALOX15 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.